23
Publications
979
Citations
20
H-Index
1965
Active since
Kirk L. Stevens is an author at GlaxoSmithKline (United States) specializing in natural sciences, pharmacology, and drug discovery.
Top concepts
Natural SciencesPharmacologyMedicineDrug DiscoveryBiochemistryMedicinal ChemistryOrganic ChemistryEngineeringChemistryPharmacotherapy
Publications per year
1965–2016
23
23
Total Synthesis of Altohyrtin A (Spongistatin 1): Part 1
Jiasheng Guo, Kevin J. Duffy, Kirk L. Stevens et al. · Angewandte Chemie International Edition · 1998 · 128 citations · Full text
Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors
Kirk L. Stevens, David Jung, Michael J. Alberti et al. · Organic Letters · 2005 · 87 citations
Medicinal Chemistry, Heterocyclic, P38 Kinase Inhibitors +14
A Convergent Approach to Coenzyme Q
Bruce H. Lipshutz, Gerd Bülow, Fernando Fernández‐Lázaro et al. · Journal of the American Chemical Society · 1999 · 63 citations
Stanley D. Chamberlain, Anikó M. Redman, Joseph W. Wilson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 57 citations · Full text
Rows per page
1–5 of 23